128
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A Case of Persistent Macular Edema and a Disappearing Tattoo

, MD & , MD, PhD
Pages 123-126 | Received 15 Sep 2022, Accepted 25 Nov 2022, Published online: 13 Jan 2023

References

  • Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P, Murray PI. Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol. 2004;88(9):1159. doi:10.1136/bjo.2003.037226.
  • Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80(9):844. doi:10.1136/bjo.80.9.844.
  • Prieto-del-Cura M, González-Guijarro JJ. Risk factors for ocular complications in adult patients with uveitis. Eur J Ophthalmol. 2020;30(6):1381–1389. doi:10.1177/1120672119899379.
  • Verhagen FH, Wijnhoven R, Ossewaarde-van Norel J, et al. Prevalence and characteristics of ocular pain in non-infectious uveitis: a quality of life study. Br J Ophthalmol. 2018;102(8):1160. doi:10.1136/bjophthalmol-2017-311575.
  • Matas J, Llorenç V, Fonollosa A, et al. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis. PLoS One. 2019;14(1):e0210799. doi:10.1371/journal.pone.0210799.
  • Lardenoye CWTA, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–1449. doi:10.1016/j.ophtha.2006.03.027.
  • Nguyen AH, Mekonnen B, Kim E, Acharya NR. Clinical outcomes of pediatric macular edema associated with non-infectious uveitis. J Ophthalmic Inflamm Infect. 2021;11(1):8. doi:10.1186/s12348-021-00236-4.
  • Ostheimer TA, Burkholder BM, Leung TG, Butler NJ, Dunn JP, Thorne JE. Tattoo-associated uveitis. Am J Ophthalmol. 2014;158(3):637–643.e1. doi:10.1016/j.ajo.2014.05.019.
  • Saliba N, Owen ME, Beare N. Tattoo-associated uveitis. Eye. 2010;24(8):1406. doi:10.1038/eye.2010.17.
  • Post J, Hull P. Tattoo reactions as a sign of sarcoidosis. CMAJ. 2012;184(4):432. doi:10.1503/cmaj.110696.
  • Rorsman H, Brehmer-Andersson E, Dahlquist I, et al. Tattoo granuloma and uveitis. Lancet. 1969;294(7610):27–28. doi:10.1016/S0140-6736(69)92600-2.
  • Piggott KD, Rao PK. Blurry vision and a black ink tattoo. JAMA. 2019;321(7):699–700. doi:10.1001/jama.2018.20671.
  • Reddy AK, Cabrera M, Yeh S, Davis JL, Albini TA. Optical coherence tomography–guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes. RETINA. 2014;34(12). doi:10.1097/IAE.0000000000000274.
  • Acharya NR, Hong KC, Lee SM. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009;148(2):303–309.e2. doi:10.1016/j.ajo.2009.03.028.
  • Mansour AM, Arevalo JF, Fardeau C, et al. Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Can J Ophthalmol. 2012;47(3):269–274. doi:10.1016/j.jcjo.2012.03.042.
  • Early Treatment Diabetic Retinopathy Study Research Group. Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema: early treatment diabetic retinopathy study report number 2. Ophthalmology. 1987;94(7):761–774. doi:10.1016/S0161-6420(87)33527-4.
  • Kim EJ, Lin WV, Rodriguez SM, Chen A, Loya A, Weng CY. Treatment of diabetic macular edema. Curr Diab Rep. 2019;19(9):68. doi:10.1007/s11892-019-1188-4.
  • Munk MR, Jampol LM, Simader C, et al. Differentiation of diabetic macular edema from pseudophakic cystoid macular edema by spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2015;56(11):6724–6733. doi:10.1167/iovs.15-17042.
  • Dysli M, Rückert R, Munk MR. Differentiation of underlying pathologies of macular edema using spectral domain optical coherence tomography (SD-OCT). Null. 2019;27(3):474–483. doi:10.1080/09273948.2019.1603313.
  • Kluger N. Tattoo-associated uveitis with or without systemic sarcoidosis: a comparative review of the literature. J Eur Acad Dermatol Venereol. 2018;32(11):1852–1861. doi:10.1111/jdv.15070.
  • Radetic M, Khan S, Venkat A, Mendel T, Phelan M. A tattoo granuloma with uveitis (TAGU) without sarcoidosis. Am J Emerg Med. 2020;38(11):2489.e3–2489.e5. doi:10.1016/j.ajem.2020.05.106.
  • Sharma OP. Markers of sarcoidosis activity. CHEST. 1986;90(4):471–473. doi:10.1378/chest.90.4.471.
  • Mukai T, Fujiwara D, Miyake T, Fujita S, Morizane S, Morita Y. Tattoo skin reaction as a skin manifestation of systemic sarcoidosis. Mod Rheumatol Case Rep. 2021;5(1):167–171. doi:10.1080/24725625.2020.1816645.
  • Tiew S. Tattoo-associated panuveitis: a 10-year follow-up. Eur J Ophthalmol. 2019;29(1_suppl):18–21. doi:10.1177/1120672119846341.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.